286 related articles for article (PubMed ID: 12435904)
1. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia.
Velanovich V; Hollingsworth J; Suresh P; Ben-Menachem T
Dig Surg; 2002; 19(5):349-53. PubMed ID: 12435904
[TBL] [Abstract][Full Text] [Related]
2. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
3. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux and cancer.
Turcotte S; Duranceau A
Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
[TBL] [Abstract][Full Text] [Related]
5. Association of adenocarcinomas of the distal esophagus, "gastroesophageal junction," and "gastric cardia" with gastric pathology.
Wijetunge S; Ma Y; DeMeester S; Hagen J; DeMeester T; Chandrasoma P
Am J Surg Pathol; 2010 Oct; 34(10):1521-7. PubMed ID: 20871225
[TBL] [Abstract][Full Text] [Related]
6. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
[TBL] [Abstract][Full Text] [Related]
7. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia.
Chak A; Faulx A; Eng C; Grady W; Kinnard M; Ochs-Balcom H; Falk G
Cancer; 2006 Nov; 107(9):2160-6. PubMed ID: 17019737
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M
World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
11. A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap.
Chandrasoma P; DeMeester T
Adv Exp Med Biol; 2016; 908():41-78. PubMed ID: 27573767
[TBL] [Abstract][Full Text] [Related]
12. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
Dixon JL; Copeland LA; Zeber JE; MacCarthy AA; Reznik SI; Smythe WR; Rascoe PA
Dis Esophagus; 2016 Oct; 29(7):747-751. PubMed ID: 26455587
[TBL] [Abstract][Full Text] [Related]
13. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
14. [Intestinal metaplasia at the esophagogastric junction. Prevelence and association in patients undergoing endoscopy].
Castro ML; Fachal C; Pineda JR; Domínguez F; Prada JI; Hermo JA; Suso J; Clofent J
Gastroenterol Hepatol; 2002 Oct; 25(8):487-92. PubMed ID: 12361529
[TBL] [Abstract][Full Text] [Related]
15. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction.
Marsman WA; Tytgat GN; ten Kate FJ; van Lanschot JJ
J Surg Oncol; 2005 Dec; 92(3):160-8. PubMed ID: 16299781
[TBL] [Abstract][Full Text] [Related]
16. The continuum of GERD complications.
Fennerty MB
Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S33-50. PubMed ID: 14705380
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD.
Kearney DJ; Crump C; Maynard C; Boyko EJ
Gastrointest Endosc; 2003 Jun; 57(7):823-9. PubMed ID: 12776027
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.
DeMeester SR
Ann Surg Oncol; 2006 Jan; 13(1):12-30. PubMed ID: 16378161
[TBL] [Abstract][Full Text] [Related]
20. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study.
Leodolter A; Nocon M; Vieth M; Lind T; Jaspersen D; Richter K; Willich S; Stolte M; Malfertheiner P; Labenz J
Scand J Gastroenterol; 2012 Dec; 47(12):1429-35. PubMed ID: 23110405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
